home.aspx
 
EVENTS

The Digital Pharma Advances
THE DIGITAL PHARMA ADVANCES
January 29-29, 2020
Powerfully Target & Engage HCPs & Patients & Deliver Real-World Results With Integrated, Innovative Digital Strategies.Customer-Centric, Value-Adding, Multi-Channel Digital Pharma Marketing Strategies.

4th Annual Microbiome Movement, Drug Development, Europe
4TH ANNUAL MICROBIOME MOVEMENT, DRUG DEVELOPMENT, EUROPE
February 04-05, 2020
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effecti...

CAE Healthcare

SHARESHARESHARE
CAE Healthcare: Providing solutions for simulation-based medical education (SBME) that improve healthcare, clinical competency, and patient CAE Healthcare delivers advanced, state-of-the-art simulation-based training that enables healthcare professionals to provide safer, high-quality care. Our end-to-end spectrum of solutions include patient, imaging, interventional and surgical simulation, audiovisual solutions, learning applications, and center management programs to drive the future of innovation in training for the benefit of patients and healthcare providers the world over.
SHARESHARESHARE

RELATED NEWS


Research and Markets has announced the addition of the "Global Pharmaceutical Contract Manufacturing Market 2016-2020" report to their offering. The global pharmaceutical contract manufacturing market to grow at a CAGR of 6.91% during the period 2016-2020. The report covers the present scenario and the growth prospects of the global pharmaceutical contract manufacturing market for 2016-2020. To calculate the market size, the report considers the revenue generated from various pharmaceutical dru...
GLOBENEWSWIRE.COM
READ MORE

Denovo Biopharma LLC, a leading company in precision medicine announces the plan to initiate a biomarker driven global phase 3 clinical trial for its lead drug DB102 as a first line therapy for diffuse large B-cell lymphoma (DLBCL) patients this year....

READ MORE

Regulations such as EU 2016/161, which has to be implemented by February 9, 2019, require innovative solutions to protect patients against falsified medicines. At Pharmapack in Paris, Schreiner MediPharm will be presenting its extensive portfolio of customized Pharma-Security solutions to safeguard the supply chain in Hall 4, Stand M31, on February 1 and 2, 2017. A newly developed label that demonstrates a combination of diverse digital security features on a Booklet-Label with an integrated fir...
WORLDPRESSONLINE.COM
READ MORE

A revamped North American trade deal nearing passage in Congress gives both the White House and Democrats a chance to claim victory and offers farmers and businesses clearer rules governing the vast flow of goods among the United States, Canada and Mexico. But the pact leaves at least one surprising loser: the pharmaceutical industry, a near-invincible lobbying powerhouse in Washington. To satisfy House Democrats, the Trump administration removed a provision that would have given the makers of u...

READ MORE

Drugmakers have often lambasted the U.S. Patent and Trademark Offices (PTOs) inter partes review system, but now Gilead Sciences is hoping to use it to its advantage. The drugmaker is taking on the U.S. government, arguing the Department of Health and Human Services patents covering preventive uses of its HIV drug Truvada are invalid. Gilead says it stronglybelieves HHS pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) patents for Truvada granted since 2015 are invalid. It'...

READ MORE

Tarrytown, NY-based Regeneron Pharmaceuticals and Paris-based Sanofi restructured a 2015 agreement to develop immuno-oncology (I/O) treatments. That deal was scheduled to wrap in 2020, but the revision adds two clinical-stage bispecific antibodies to the collaboration. The revision lets Regeneron hold all rights to its other I/O discovery and development programs. It gives Sanofi more flexibility in advancing its early-stage I/O pipeline by itself. Under the terms of the restructuring, Sanofi is...

READ MORE

EVENTS

The Digital Pharma Advances
THE DIGITAL PHARMA ADVANCES
January 29-29, 2020
Powerfully Target & Engage HCPs & Patients & Deliver Real-World Results With Integrated, Innovative Digital Strategies.Customer-Centric, Value-Adding, Multi-Channel Digital Pharma Marketing Strategies.

4th Annual Microbiome Movement, Drug Development, Europe
4TH ANNUAL MICROBIOME MOVEMENT, DRUG DEVELOPMENT, EUROPE
February 04-05, 2020
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effecti...